Endogenex

Plymouth, MN

Endogenex develops an endoscopic procedure to help patients with type 2 diabetes regain control of their blood glucose levels. Established in 2017, Endogenex has developed a novel therapy that utilizes pulsed electric fields to promote regeneration of the duodenal mucosa for improvement in glycemic control in patients with T2D.

Company Details

Founded: 2017
Employees: Between 20 - 50 employees
Raised: $112,996,352
Headquarters Location: Plymouth, MN
Public: No
Acquired: No
CEO: Stacey Pugh
Founders: John A Deedrick
Michael Brenzel
Paul Hindrichs

Company Collections

These are collections Endogenex is a part of. Click on the collection name to view similar companies.

Endogenex's Tech Stack